Skip to main content
PMC home page
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 1999 Sep;83(9):1027–1031. doi: 10.1136/bjo.83.9.1027

Risk factors for treatment outcome of suspected microbial keratitis

N Morlet, D Minassian, J Butcher, O the
PMCID: PMC1723169  PMID: 10460769

Abstract

BACKGROUND—Primary treatment for suspected microbial keratitis is generally successful. Although risks such as contact lens use are well recognised as causative factors for microbial keratitis, little is known about the risk factors that influence treatment outcome. The present study evaluates the risk factors assessed at diagnosis as prognostic indicators of primary treatment failure.
METHODS—Patients were prospectively enrolled in the ofloxacin treatment trial and data concerning symptoms, treatments, past and concurrent eye disease were collected along with the measurement of corneal ulcer size at the slit lamp. All patients were scraped for microbiological investigation, and treated with either ofloxacin (0.3%) or standard therapy of fortified cefuroxime and gentamicin drops. Treatment success was complete healing of the ulcer with zero dimensions of the epithelial defect within 2 weeks of start of treatment. The important prognostic indicators were selected by comparison among those who failed treatment, had delayed healing, or were culture positive with other patients using univariate and stratified analysis. These were then used in a Poisson model for multiple regression analysis to estimate the relative risk of the main prognostic variables.
RESULTS—Of the 118 patients enrolled in the study, 14 were identified as primary treatment failures, 17 had slow healing, and 15 indolent ulcers. There were 49 culture positive patients. The multivariate analysis identified that large culture positive ulcers in patients 60 years or older had 5.5 times the risk of primary treatment failure (p<0.001). Significant predictors of slow healing were previous ocular disease and a positive culture; significant predictors of indolent ulceration were previous ocular disease and steroid use at diagnosis; the main predictor of a culture positive result was ulcer size.
CONCLUSIONS—Elderly patients with large ulcers were more likely to be culture positive, fail primary therapy, and require surgical intervention. A positive microbial culture provided prognostic information regardless of the organism isolated. However, this information was of less value for those with small ulcers and for younger patients.



Full Text

The Full Text of this article is available as a PDF (85.9 KB).

Figure 1  .

Figure 1  

Open in a new tab

Age distribution and culture results of patients with suspected microbial keratitis.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Blanton C. L., Rapuano C. J., Cohen E. J., Laibson P. R. Initial treatment of microbial keratitis. CLAO J. 1996 Apr;22(2):136–140. [PubMed] [Google Scholar]
  2. Brown H. H., Glasgow B. J., Foos R. Y. Ultrastructural and immunohistochemical features of coronal adenomas. Am J Ophthalmol. 1991 Jul 15;112(1):34–40. doi: 10.1016/s0002-9394(14)76209-9. [DOI] [PubMed] [Google Scholar]
  3. Coster D. J., Badenoch P. R. Host, microbial, and pharmacological factors affecting the outcome of suppurative keratitis. Br J Ophthalmol. 1987 Feb;71(2):96–101. doi: 10.1136/bjo.71.2.96. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Gudmundsson O. G., Ormerod L. D., Kenyon K. R., Glynn R. J., Baker A. S., Haaf J., Lubars S., Abelson M. B., Boruchoff S. A., Foster C. S. Factors influencing predilection and outcome in bacterial keratitis. Cornea. 1989;8(2):115–121. [PubMed] [Google Scholar]
  5. Jacobson J. A., Call N. B., Kasworm E. M., Dirks M. S., Turner R. B. Safety and efficacy of topical norfloxacin versus tobramycin in the treatment of external ocular infections. Antimicrob Agents Chemother. 1988 Dec;32(12):1820–1824. doi: 10.1128/aac.32.12.1820. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. McDonnell P. J. Empirical or culture-guided therapy for microbial keratitis? A plea for data. Arch Ophthalmol. 1996 Jan;114(1):84–87. doi: 10.1001/archopht.1996.01100130080013. [DOI] [PubMed] [Google Scholar]
  7. McDonnell P. J., Nobe J., Gauderman W. J., Lee P., Aiello A., Trousdale M. Community care of corneal ulcers. Am J Ophthalmol. 1992 Nov 15;114(5):531–538. doi: 10.1016/s0002-9394(14)74479-4. [DOI] [PubMed] [Google Scholar]
  8. McLeod S. D., Kolahdouz-Isfahani A., Rostamian K., Flowers C. W., Lee P. P., McDonnell P. J. The role of smears, cultures, and antibiotic sensitivity testing in the management of suspected infectious keratitis. Ophthalmology. 1996 Jan;103(1):23–28. doi: 10.1016/s0161-6420(96)30738-0. [DOI] [PubMed] [Google Scholar]
  9. McLeod S. D., LaBree L. D., Tayyanipour R., Flowers C. W., Lee P. P., McDonnell P. J. The importance of initial management in the treatment of severe infectious corneal ulcers. Ophthalmology. 1995 Dec;102(12):1943–1948. doi: 10.1016/s0161-6420(95)30771-3. [DOI] [PubMed] [Google Scholar]
  10. Musch D. C., Sugar A., Meyer R. F. Demographic and predisposing factors in corneal ulceration. Arch Ophthalmol. 1983 Oct;101(10):1545–1548. doi: 10.1001/archopht.1983.01040020547007. [DOI] [PubMed] [Google Scholar]
  11. O'Brien T. P., Maguire M. G., Fink N. E., Alfonso E., McDonnell P. Efficacy of ofloxacin vs cefazolin and tobramycin in the therapy for bacterial keratitis. Report from the Bacterial Keratitis Study Research Group. Arch Ophthalmol. 1995 Oct;113(10):1257–1265. doi: 10.1001/archopht.1995.01100100045026. [DOI] [PubMed] [Google Scholar]
  12. Parks D. J., Abrams D. A., Sarfarazi F. A., Katz H. R. Comparison of topical ciprofloxacin to conventional antibiotic therapy in the treatment of ulcerative keratitis. Am J Ophthalmol. 1993 Apr 15;115(4):471–477. doi: 10.1016/s0002-9394(14)74449-6. [DOI] [PubMed] [Google Scholar]
  13. Stern G. A., Buttross M. Use of corticosteroids in combination with antimicrobial drugs in the treatment of infectious corneal disease. Ophthalmology. 1991 Jun;98(6):847–853. doi: 10.1016/s0161-6420(91)32211-5. [DOI] [PubMed] [Google Scholar]
  14. Wilhelmus K. R., Hyndiuk R. A., Caldwell D. R., Abshire R. L., Folkens A. T., Godio L. B. 0.3% ciprofloxacin ophthalmic ointment in the treatment of bacterial keratitis. The Ciprofloxacin Ointment/Bacterial Keratitis Study Group. Arch Ophthalmol. 1993 Sep;111(9):1210–1218. doi: 10.1001/archopht.1993.01090090062020. [DOI] [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES